Alimera Sciences, Inc (ALIM) Covered Calls

Alimera Sciences Inc is a biopharmaceutical company that is engaged in the research, development, and commercialization of ophthalmic pharmaceuticals.

You can sell covered calls on Alimera Sciences, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ALIM (prices last updated Thu 4:16 PM ET):

Alimera Sciences, Inc (ALIM) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
0.87 -0.02 0.86 0.88 256K 3.5 0.1B
Covered Calls For Alimera Sciences, Inc (ALIM)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
May 17 2.5 0.00 0.88 0.0% 0.0%
Jun 21 2.5 0.00 0.88 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Alimera Sciences, Inc. operates a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. It focuses on diseases affecting the back of the eye, or retina. Its primary product, ILUVIEN, for the treatment of vision impairment associated with chronic diabetic macular edema considered insufficiently responsive to available therapies. Alimera Sciences was founded on June 4, 2003 by C. Daniel Myers and David R. Holland and is headquartered in Alpharetta, GA.